Change in tropism upon immune escape by human immunodeficiency virus
- PMID: 7707545
- PMCID: PMC189019
- DOI: 10.1128/JVI.69.5.3167-3170.1995
Change in tropism upon immune escape by human immunodeficiency virus
Abstract
The V3 loop of human immunodeficiency virus type 1 is both a determinant of viral cell tropism and a target for neutralizing antibodies. This relationship was investigated. Selection of a dual-tropic (T cells and macrophages) virus to replicate in CD4+ brain cells results in loss of macrophage tropism and of neutralization by an anti-V3 loop monoclonal antibody. Moreover, selection of the brain-selected variant to escape from V3 loop-specific neutralizing monoclonal antibodies results in the reduction or loss of brain cell tropism and the reacquisition of macrophage tropism. These data may indicate that the antigenic diversification of human immunodeficiency virus type 1 apparent after seroconversion can be selected either by immune responses or by colonization of new cell types.
Similar articles
-
The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1291-9. doi: 10.1089/aid.1997.13.1291. AIDS Res Hum Retroviruses. 1997. PMID: 9339846
-
Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.AIDS. 1993 May;7(5):639-46. AIDS. 1993. PMID: 7686374
-
Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.J Virol. 1999 Jul;73(7):5520-6. doi: 10.1128/JVI.73.7.5520-5526.1999. J Virol. 1999. PMID: 10364300 Free PMC article.
-
Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.Chem Immunol. 1993;56:1-33. Chem Immunol. 1993. PMID: 8383980 Review. No abstract available.
-
Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.J Gen Virol. 1996 Dec;77 ( Pt 12):2905-19. doi: 10.1099/0022-1317-77-12-2905. J Gen Virol. 1996. PMID: 9000081 Review. No abstract available.
Cited by
-
Genetic variation and HIV-associated neurologic disease.Adv Virus Res. 2013;87:183-240. doi: 10.1016/B978-0-12-407698-3.00006-5. Adv Virus Res. 2013. PMID: 23809924 Free PMC article. Review.
-
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Microbiol Mol Biol Rev. 2001 Sep;65(3):371-89, table of contents. doi: 10.1128/MMBR.65.3.371-389.2001. Microbiol Mol Biol Rev. 2001. PMID: 11528001 Free PMC article. Review.
-
A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.Retrovirology. 2008 Aug 22;5:77. doi: 10.1186/1742-4690-5-77. Retrovirology. 2008. PMID: 18721458 Free PMC article.
-
Immune escape mutations selected by neutralizing antibodies in natural HIV-1 infection can alter coreceptor usage repertoire of the transmitted/founder virus.Virology. 2022 Mar;568:72-76. doi: 10.1016/j.virol.2022.01.010. Epub 2022 Jan 24. Virology. 2022. PMID: 35144109 Free PMC article.
-
Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent.J Virol. 1997 Feb;71(2):1692-6. doi: 10.1128/JVI.71.2.1692-1696.1997. J Virol. 1997. PMID: 8995702 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials